M&T Bank’s Inovio Pharmaceuticals INO Stock Holding History

M&T Bank’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-880	Closed	-$104K	–	2182
2014 Q3	$104K	Buy	+880	New	+$110K	﹤0.01%	2013

Other funds holding INO

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CCA

Catalyst Capital Advisors Huntington, New York $5.37B AUM 18.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

M&T Bank's INO Position: Q4 2014 in Review

M&T Bank sold out of Inovio Pharmaceuticals (INO) in Q4 2014, closing a stake of 880 shares — an estimated $104K sold.

M&T Bank first reported a position in INO in Q3 2014 and held it in 1 quarter. The position peaked at $104K in Q3 2014. 94 funds tracked by Wall St. Rank hold INO as of Q4 2014.

M&T Bank reported no remaining Inovio Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
M&T Bank sold 880 Inovio Pharmaceuticals shares in Q4 2014, an estimated $104K.
M&T Bank first reported a position in Inovio Pharmaceuticals in Q3 2014 and held it in 1 quarter.
M&T Bank's Inovio Pharmaceuticals position peaked at $104K in Q3 2014.
94 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2014.

Based on M&T Bank's 13F filing for Q4 2014, filed 12 Feb 2015.